---
figid: PMC8657787__ijms-22-12865-g003
figtitle: 'Protein Tyrosine Phosphatases: Mechanisms in Cancer'
organisms:
- Homo sapiens
- Mus musculus
- Rat sarcoma virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8657787
filename: ijms-22-12865-g003.jpg
figlink: /pmc/articles/PMC8657787/figure/ijms-22-12865-f003/
number: F3
caption: PTPs that affect RTK-associated PI3K-AKT and Ras-Raf-Mek-Erk Signaling. The
  PI3K-AKT pathway and MAPK signaling cascade are downstream of RTKs. The GRB2-SOS-Gab1
  complex can enhance PI3K and MAPK signaling. Furthermore, PI3K is recruited to intracellular
  phosphotyrosine residues of activated RTKs. PTPs dephosphorylate inhibitors (CBP
  = Csk binding protein) of these oncogenic pathways (SHP-2), or dephosphorylate the
  RTK itself (PTPN12, cPAcP). For a more in-depth discussion of the mechanism of action
  for each PTP, refer to . Adapted from “PI3K/Akt, RAS/MAPK, JAK/STAT Signaling”,
  by BioRender.com (accessed on 28 September 2021). Retrieved from https://app.biorender.com/biorender-templates
  (accessed on 28 September 2021).
papertitle: 'Protein Tyrosine Phosphatases: Mechanisms in Cancer.'
reftext: Vignesh Sivaganesh, et al. Int J Mol Sci. 2021 Dec;22(23):12865.
year: '2021'
doi: 10.3390/ijms222312865
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: breast cancer | gastric cancer | prostate cancer | PTP | protein tyrosine
  phosphatase | protein tyrosine kinase | receptor tyrosine kinase | oncogene | tumor
  suppressor
automl_pathway: 0.9490513
figid_alias: PMC8657787__F3
figtype: Figure
redirect_from: /figures/PMC8657787__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8657787__ijms-22-12865-g003.html
  '@type': Dataset
  description: PTPs that affect RTK-associated PI3K-AKT and Ras-Raf-Mek-Erk Signaling.
    The PI3K-AKT pathway and MAPK signaling cascade are downstream of RTKs. The GRB2-SOS-Gab1
    complex can enhance PI3K and MAPK signaling. Furthermore, PI3K is recruited to
    intracellular phosphotyrosine residues of activated RTKs. PTPs dephosphorylate
    inhibitors (CBP = Csk binding protein) of these oncogenic pathways (SHP-2), or
    dephosphorylate the RTK itself (PTPN12, cPAcP). For a more in-depth discussion
    of the mechanism of action for each PTP, refer to . Adapted from “PI3K/Akt, RAS/MAPK,
    JAK/STAT Signaling”, by BioRender.com (accessed on 28 September 2021). Retrieved
    from https://app.biorender.com/biorender-templates (accessed on 28 September 2021).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Grb2
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - Crebbp
  - Pag1
  - Cytip
  - Csk
  - Gab1
  - Ptpn11
  - Ecm1
  - Ppp1r13b
  - Pik3ca
  - Pik3r1
  - Ptpn12
  - Pdk1
  - Pdpk1
  - Pten
  - Akt1
  - KRAS
  - HRAS
  - NRAS
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MTG1
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - CSK
  - GAB1
  - PIGU
  - PTPN11
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PTPN12
  - PDK1
  - PDPK1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - Ras64B
  - Ras85D
  - drk
  - Sos
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - CBP
  - nej
  - eIF4E1
  - costakink
  - dos
  - csw
  - Myb
  - Pi3K21B
  - Taf5
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Pi3K59F
  - Pi3K68D
  - Akt
---
